Skip to main content
Gut logoLink to Gut
. 1993;34(2 Suppl):S50–S51. doi: 10.1136/gut.34.2_suppl.s50

Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France.

S Ranger 1, P Martin 1, M C Roussanne 1, F Denis 1
PMCID: PMC1374005  PMID: 7686115

Abstract

In this study of hepatitis C virus (HCV) infection prevalence in France, the prevalence of antibodies to HCV (as tested by second generation ELISA, with RIBA-2 confirmation in ELISA 2 positive samples) was found to be low (0.3%) in the healthy general population. HCV infection prevalence increased in the general population in association with African or Asian origin and risk factors such as bisexuality, previous history of transfusion, and intravenous drug abuse. The prevalence of anti-HCV infection was also higher in specific patient groups infected with HIV or a history of transfusion or haemodialysis.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aussel L., Denis F., Ranger S., Martin P., Caillaud M., Alain J., Baudet J., Tabaste J. L. Recherche des anticorps contre le virus de l'hépatite C chez les femmes enceintes d'origine étrangère vivant en France. Pathol Biol (Paris) 1991 Dec;39(10):991–996. [PubMed] [Google Scholar]
  2. Choo Q. L., Weiner A. J., Overby L. R., Kuo G., Houghton M., Bradley D. W. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull. 1990 Apr;46(2):423–441. doi: 10.1093/oxfordjournals.bmb.a072408. [DOI] [PubMed] [Google Scholar]
  3. Ranger S., Aussel L., Weinbreck P., Loustaud V., Rogues A. M., Mounier M., Delpeyroux C., Denis F. Séroprévalence de l'hépatite C chez les sujets contaminés par le virus de l'immunodéficience humaine. Pathol Biol (Paris) 1991 Feb;39(2):126–130. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES